Key terms
About OCX
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest OCX news
Apr 15
10:45am ET
Biotech Alert: Searches spiking for these stocks today
Apr 12
6:22am ET
OncoCyte Corp Announces Equity Placement and Fundraising Efforts
Apr 12
6:06am ET
OncoCyte reports Q4 revenue $314,000, consensus $320,000
Apr 12
5:11am ET
OncoCyte to sell 5.077M shares at $ 2.92 in private placement
Apr 11
5:31pm ET
OncoCyte, BioRad to partner on global launch of GraftAssure assay
Feb 26
8:30am ET
Two new option listings and option delistings on February 26th
OCX Financials
Key terms
Ad Feedback
OCX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
OCX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
